A4S: A user-friendly graphical tool for pharmacokinetic and pharmacodynamic (PK/PD) simulation

Effective communication of PK/PD principles and results in a biomedical research environment remains a significant challenge which can result in lack of buy-in and engagement from scientists outside the modeling and simulation communities. In our view, one of the barriers in this area is a lack of user-friendly tools which allow "non experts" to use PK/PD models without the need to develop technical skills and expertise in advanced mathematical principles and specialist software. The costs of commercial software may also prevent large-scale distribution. One attempt to address this issue internally in our research organizations has resulted in the development of the A4S ("Accelera for Sandwich") software, which is a simple-to-use, menu-drive Matlab-based PK/PD simulator targeted at biomedical researchers with little PK/PD experience.

[1]  Lawrence F. Shampine,et al.  Solving Index-1 DAEs in MATLAB and Simulink , 1999, SIAM Rev..

[2]  B. Corrigan,et al.  How Modeling and Simulation Have Enhanced Decision Making in New Drug Development , 2005, Journal of Pharmacokinetics and Pharmacodynamics.

[3]  Mats O Karlsson,et al.  Pharmacokinetic/pharmacodynamic modelling in oncological drug development. , 2005, Basic & clinical pharmacology & toxicology.

[4]  J. Black,et al.  Operational models of pharmacological agonism , 1983, Proceedings of the Royal Society of London. Series B. Biological Sciences.

[5]  Paolo Magni,et al.  TGI-Simulator: A visual tool to support the preclinical phase of the drug discovery process by assessing in silico the effect of an anticancer drug , 2012, Comput. Methods Programs Biomed..

[6]  Michael Rowley,et al.  Pharmacodynamic-pharmacokinetic integration as a guide to medicinal chemistry. , 2011, Current topics in medicinal chemistry.

[7]  Johan Gabrielsson,et al.  Pharmacokinetic-pharmacodynamic reasoning in drug discovery and early development. , 2009, Future medicinal chemistry.

[8]  Paolo Magni,et al.  Predictive Pharmacokinetic-Pharmacodynamic Modeling of Tumor Growth Kinetics in Xenograft Models after Administration of Anticancer Agents , 2004, Cancer Research.

[9]  Neil J Attkins,et al.  Quantitative pharmacological analysis of antagonist binding kinetics at CRF1 receptors in vitro and in vivo , 2011, British journal of pharmacology.

[10]  C. Mehta,et al.  The future of drug development: advancing clinical trial design , 2009, Nature Reviews Drug Discovery.

[11]  D R Mould,et al.  Basic Concepts in Population Modeling, Simulation, and Model-Based Drug Development , 2012, CPT: pharmacometrics & systems pharmacology.

[12]  C Garnett,et al.  Impact of Pharmacometric Reviews on New Drug Approval and Labeling Decisions—a Survey of 31 New Drug Applications Submitted Between 2005 and 2006 , 2007, Clinical pharmacology and therapeutics.

[13]  L Aarons,et al.  Role of modelling and simulation in Phase I drug development. , 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[14]  Per Olsson,et al.  Modelling and simulation to improve decision-making in clinical development , 2005 .

[15]  L P Balant,et al.  Modelling during drug development. , 2000, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[16]  Lawrence F. Shampine,et al.  The MATLAB ODE Suite , 1997, SIAM J. Sci. Comput..

[17]  L. Goodman,et al.  The Pharmacological Basis of Therapeutics , 1941 .

[18]  Jürgen Brockmöller,et al.  Simulation of complex pharmacokinetic models in Microsoft EXCEL , 2007, Comput. Methods Programs Biomed..

[19]  W Ewy,et al.  Model‐based Drug Development , 2007, Clinical pharmacology and therapeutics.

[20]  Andreas Krause,et al.  Interactive Visualization and Communication for Increased Impact of Pharmacometrics , 2010, Journal of clinical pharmacology.

[21]  K Krishnan,et al.  A Spreadsheet Program for Modeling Quantitative Structure-Pharmacokinetic Relationships for Inhaled Volatile Organics in Humans , 2005, SAR and QSAR in environmental research.

[22]  H Delboy,et al.  A non-linear fitting program in pharmacokinetics with Microsoft Excel spreadsheet. , 1994, International journal of bio-medical computing.

[23]  P. Marroum,et al.  Utilisation of Pharmacokinetic-Pharmacodynamic Modelling and Simulation in Regulatory Decision-Making , 2001, Clinical pharmacokinetics.

[24]  Gianne Derks,et al.  Mathematical analysis of the pharmacokinetic-pharmacodynamic (PKPD) behaviour of monoclonal antibodies: predicting in vivo potency. , 2011, Journal of theoretical biology.

[25]  Donald E. Mager,et al.  General Pharmacokinetic Model for Drugs Exhibiting Target-Mediated Drug Disposition , 2001, Journal of Pharmacokinetics and Pharmacodynamics.

[26]  Neil Benson,et al.  Impact of protein binding on receptor occupancy: a two-compartment model. , 2010, Journal of theoretical biology.

[27]  Giuseppe De Nicolao,et al.  A Minimal Model of Tumor Growth Inhibition , 2008, IEEE Transactions on Biomedical Engineering.

[28]  A. Christopoulos,et al.  Qualitative and quantitative assessment of relative agonist efficacy. , 1999, Biochemical pharmacology.

[29]  Yong Zhang,et al.  PKSolver: An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel , 2010, Comput. Methods Programs Biomed..

[30]  Johan Gabrielsson,et al.  Pharmacokinetic and Pharmacodynamic Data Analysis: Concepts and Applications , 2002 .

[31]  Meindert Danhof,et al.  Incorporating receptor theory in mechanism-based pharmacokinetic-pharmacodynamic (PK-PD) modeling. , 2009, Drug metabolism and pharmacokinetics.

[32]  C. T. Viswanathan,et al.  Opportunities for Integration of Pharmacokinetics, Pharmacodynamics, and Toxicokinetics in Rational Drug Development , 1992, Clinical pharmacology and therapeutics.

[33]  Stephen B. Duffull,et al.  Estimation of pharmacokinetic parameters from non-compartmental variables using Microsoft Excel® , 2005, Comput. Biol. Medicine.

[34]  N. Holford,et al.  Clinical Trial Simulation: A Review , 2010, Clinical pharmacology and therapeutics.